Researchers found a paradoxical increase in thromboembolism risk in low-weight patients with atrial fibrillation and VTE who were treated with direct oral anticoagulants.
Researchers developed a protocol to demonstrate the efficacy of rivaroxaban in lowering the risk of venous thromboembolism among orthopedic joint surgery patients.
The therapy may be cost-effective for patients with a predicted 1-year VTE risk of 17.5% or more.
Results showed that mean induction times, analyzed in 170 patients, were 12.87 days in the HIV-infected patients and 11.19 days in the HIV-uninfected patients.
Surgical pulmonary embolectomy for peripheral distribution of thrombus demonstrated positive outcomes in patients with either CPE or PPE.
Short-term oral corticosteroid use associated with increased risk for sepsis, venous thromboembolismApril 27, 2017
Approximately 1 in 5 American adults use corticosteroids in the short term, which is associated with an increased risk for sepsis, venous thromboembolism, and fracture.
Researchers sought to determine the risk of venous thromboembolism associated with use of testosterone treatment.
The reduction in thromboembolism was attenuated after accounting for competing death events.
In patients with first unprovoked venous thromboembolism, adding CT to limited cancer screening may not lead to statistically higher rate of cancer detectionFebruary 02, 2016
Unprovoked venous thromboembolism has been associated with the presence of occult malignancies.